The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism

Hypertension Clinical Trial

Official title:

The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06330649
• Other study ID #: 2024-0095
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2024
• Est. completion date: August 31, 2025

Study information

• Verified date: March 2024
• Source: The University of Texas at Arlington
• Contact: Robert M Brothers, PhD
• Phone: 817-272-3288
• Email: matthew.brothers[@]uta.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of this protocol is to investigate the effect of consumption of a commercially available energy drink beverage on blood pressure, heart rate, and energy metabolism

Description:

Energy drink consumption has gained a lot in popularity and represents one of the most rapidly growing segments of the beverage industry. While regularly discussed in media outlets etc. the cardiovascular effects are not well described or well known. For example, the impacts on various cardiovascular parameters range from improved, decreased, to not impacted at all depending on the source. This can be due to a number of reasons including, study protocol design, study population tested, energy drink product used, volume consumed, etc. Accordingly, this study aims to investigate the impact of acute consumption of a standard commercially available can of energy drink beverage on the following parameters.

• Arterial blood pressure

• Heart rate

• Energy metabolism (oxygen consumption and carbon dioxide production

It is hypothesized that consumption of a 12 oz energy drink will result in modest elevations in arterial blood pressure, heart rate, and energy metabolism relative to when consuming of an equal volume of water.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: August 31, 2025
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Between ages 18-30

• Must be free of reported cardiovascular, respiratory, and metabolic diseases.

• Must be caffeine naïve

• Must be fasted

Exclusion Criteria:

• Food allergies

• pregnant women

• Breast feeding women

• Individuals with cardiac, cardiovascular, respiratory, metabolic, and/or neurological disorders

• taking any prescription vasoactive medications

• allergies to spandex/lycra

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Diet
• Hypertension

Intervention

Dietary Supplement:
• Energy Drink
This is a commercially available energy drink

Other:
• Water Control
This is a commercially available bottled water

Locations

Country	Name	City	State
United States	UT Arlington - Science and Engineering Innovation and Research Building	Arlington	Texas

Sponsors (1)

Lead Sponsor	Collaborator
The University of Texas at Arlington

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Peripheral blood pressure in millimeters of mercury	blood pressure will be measured on the upper arm using standard procedures that are done in a doctors office.	baseline & 30, 60, 90, 120 min following beverage consumption
Primary	Oxygen consumption milliliters per kilogram of body weight per minute	This will be assessed using a metabolic cart to measure the amount of oxygen that is consumed by the body.	baseline & 30, 60, 90, 120 min following beverage consumption
Primary	Heart rate in beats per minute	Heart will be measured using an electrocardiogram procedures that are done in a doctors office.	baseline & 30, 60, 90, 120 min following beverage consumption